Searchable News & Info From Reliable Online Sources.
Latest Real News From 140 News Sites Updated Every 15 Minutes.
- Call It a ‘Book-cation’ or a ‘Readaway,’ Literary Travel Is Having a Mom...
Resort book clubs, tour companies, hotel libraries and a growing number of literary festivals are offering readers new ways to indulge their interests. [TheTopNews] Read More.3 days ago - Carvana’s new vehicle strategy turns dealership into ‘playground,’ test-dr...
But don't expect Carvana to sell you a vehicle at one of its seven Stellantis franchised dealerships, marking a stark contrast from typical franchised dealers. [TheTopNews] Read More.3 days ago - Snap unveils $2,195 smart glasses after previous flops
The augmented reality glasses from Snapchat's parent company are expected to ship in autumn. [TheTopNews] Read More.3 days ago - AI Is Taking Over Hospitals
Every knowledge-based profession may one day reach the point when AI outperforms the human experts. In medicine, that day appeared to come in April. A group of primarily Harvard and Stanford researchers announced the results of a study that pitted ChatGPT against hundreds of physicians in a diagnostic obstacle course involving written medical mysteries and information from real-world patients. The bot had won, and the humans weren’t entirely happy about it.“I get a little bit queasy about how some of these results might be used,” Adam Rodman, a lead author on the study, said at a press conference just ahead of its publication in the journal Science. The work had amounted to an academic exercise, he told reporters; as thorough as it may have been, it did not prove that ChatGPT or any other AI tool was ready to become a standard part of medical practice. His caution was in line with that of other experts, yet as Rodman knew, most people will ignore the warning. AI has already wormed its way into the U.S. health-care system, evidence and safeguards be damned.Even as I was watching Rodman’s press conference, I got a message on my phone from the administrators at the medical center where I work as a pathologist. They’d emailed me to say that an “AI-powered clinical reasoning tool” was now available for me to use. This wasn’t the first time I’d gotten this sort of email; it wasn’t the second or third time either. In fact, I’ve lost count of how many generative-AI products have been rolled out to us in recent years, none of which has been approved for medical use by the FDA.This enthusiasm feels unprecedented. Health care is typically among the last fields to adopt a new technology; I still use a pager, and I send faxes on a regular basis. (Younger readers can ask Claude to explain what these things are.) A tendency toward simple tech is in part a product of doctors’ safety-focused culture: We know that any ill-timed glitch has the potential to turn deadly. But these days, clinicians are allowed—encouraged, even—to run wild with the latest software, guided by a generic warning that “AI can make mistakes.”Those mistakes can be consequential. Although Rodman’s research shows that generative AI can help diagnose rare diseases or make sense of unusual symptoms, a randomized trial that was published in NEJM AI just the week… [TheTopNews] Read More.3 days ago - Ozempic users may be making a major weight-loss mistake, new study suggests
Among those taking GLP-1 medications for weight loss, exercise rates are decreasing, according to new research.The study, set to be presented at ENDO 2026 (the Endocrine Society's annual meeting) in Chicago this week, found that adults with obesity who lost weight with a GLP-1, such as Ozempic or Wegovy, "significantly reduced" their physical activity.In an Endocrine Society press release, study lead Sajana Maharjan, MD, of HSHS St. John's Hospital in Springfield, Illinois, noted that GLP-1 drugs like semaglutide, liraglutide, dulaglutide and tirzepatide reduce both fat and lean muscle mass.'WILD WEST' PEPTIDE CRAZE SURGES BEYOND GLP-1S AS FDA FACES PRESSURE TO EASE ACCESSThis means physical activity is "essential for preserving strength and long-term health," she said.The study, reportedly the first of its kind, considered data from a National Institutes of Health research program that linked participant records with fitness tracker activity.Researchers analyzed data from 753 people with obesity who initiated a GLP-1 medication. The cohort was mostly female, at a mean age of 52.7 years.Comparing activity in participants before and after beginning treatment, the average number of steps decreased from 5,047 to 4,487 per day. Moderate-to-vigorous physical activity fell from 28 to 22 minutes per day, the study found.The largest declines were observed in men and in those with joint or muscle pain. Other factors like age, heart failure or prior stroke did not change results.OZEMPIC ‘MICRODOSING’ IS THE NEW WEIGHT-LOSS TREND: SHOULD YOU TRY IT?Although many people might assume that losing weight with these medications would lead to increased physical activity, the study found no evidence that it did, according to Maharjan."The findings in our study reinforce that exercise cannot be optional for people taking these medications," he said. "People need targeted interventions that encourage physical activity alongside medication for obesity."FITNESS EXPERT REVEALS SIMPLE RULE TO GET IN SHAPE WITHOUT DREADING THE GYM: 'JUST MOVE'The study was retrospective and observational, meaning it could only display an association, not a direct cause. The participants were also mostly middle-aged women, which could limit the scope of who is most impacted, the researchers noted.Other factors that were not measured include exercise habits before starting treatment, motivation levels and guidance from a physician.Dr. Peter Balazs MD, a hormone and weight-loss specialist practicing in New York and New Jersey, echoed in an interview with Fox News Digital that weight loss does not automatically lead to increased mobility or greater motivation to exercise."In fact, being in… [TheTopNews] Read More.3 days ago
« Previous
1
…
83
84
85
86
87
…
112
Next »
Resort book clubs, tour companies, hotel libraries and a growing number of literary festivals are offering readers new ways to indulge their interests. [TheTopNews] Read More.
3 days ago
But don't expect Carvana to sell you a vehicle at one of its seven Stellantis franchised dealerships, marking a stark contrast from typical franchised dealers. [TheTopNews] Read More.
3 days ago
The augmented reality glasses from Snapchat's parent company are expected to ship in autumn. [TheTopNews] Read More.
3 days ago
Every knowledge-based profession may one day reach the point when AI outperforms the human experts. In medicine, that day appeared to come in April. A group of primarily Harvard and Stanford researchers announced the results of a study that pitted ChatGPT against hundreds of physicians in a diagnostic obstacle course involving written medical mysteries and information from real-world patients. The bot had won, and the humans weren’t entirely happy about it.“I get a little bit queasy about how some of these results might be used,” Adam Rodman, a lead author on the study, said at a press conference just ahead of its publication in the journal Science. The work had amounted to an academic exercise, he told reporters; as thorough as it may have been, it did not prove that ChatGPT or any other AI tool was ready to become a standard part of medical practice. His caution was in line with that of other experts, yet as Rodman knew, most people will ignore the warning. AI has already wormed its way into the U.S. health-care system, evidence and safeguards be damned.Even as I was watching Rodman’s press conference, I got a message on my phone from the administrators at the medical center where I work as a pathologist. They’d emailed me to say that an “AI-powered clinical reasoning tool” was now available for me to use. This wasn’t the first time I’d gotten this sort of email; it wasn’t the second or third time either. In fact, I’ve lost count of how many generative-AI products have been rolled out to us in recent years, none of which has been approved for medical use by the FDA.This enthusiasm feels unprecedented. Health care is typically among the last fields to adopt a new technology; I still use a pager, and I send faxes on a regular basis. (Younger readers can ask Claude to explain what these things are.) A tendency toward simple tech is in part a product of doctors’ safety-focused culture: We know that any ill-timed glitch has the potential to turn deadly. But these days, clinicians are allowed—encouraged, even—to run wild with the latest software, guided by a generic warning that “AI can make mistakes.”Those mistakes can be consequential. Although Rodman’s research shows that generative AI can help diagnose rare diseases or make sense of unusual symptoms, a randomized trial that was published in NEJM AI just the week… [TheTopNews] Read More.
3 days ago
Among those taking GLP-1 medications for weight loss, exercise rates are decreasing, according to new research.The study, set to be presented at ENDO 2026 (the Endocrine Society's annual meeting) in Chicago this week, found that adults with obesity who lost weight with a GLP-1, such as Ozempic or Wegovy, "significantly reduced" their physical activity.In an Endocrine Society press release, study lead Sajana Maharjan, MD, of HSHS St. John's Hospital in Springfield, Illinois, noted that GLP-1 drugs like semaglutide, liraglutide, dulaglutide and tirzepatide reduce both fat and lean muscle mass.'WILD WEST' PEPTIDE CRAZE SURGES BEYOND GLP-1S AS FDA FACES PRESSURE TO EASE ACCESSThis means physical activity is "essential for preserving strength and long-term health," she said.The study, reportedly the first of its kind, considered data from a National Institutes of Health research program that linked participant records with fitness tracker activity.Researchers analyzed data from 753 people with obesity who initiated a GLP-1 medication. The cohort was mostly female, at a mean age of 52.7 years.Comparing activity in participants before and after beginning treatment, the average number of steps decreased from 5,047 to 4,487 per day. Moderate-to-vigorous physical activity fell from 28 to 22 minutes per day, the study found.The largest declines were observed in men and in those with joint or muscle pain. Other factors like age, heart failure or prior stroke did not change results.OZEMPIC ‘MICRODOSING’ IS THE NEW WEIGHT-LOSS TREND: SHOULD YOU TRY IT?Although many people might assume that losing weight with these medications would lead to increased physical activity, the study found no evidence that it did, according to Maharjan."The findings in our study reinforce that exercise cannot be optional for people taking these medications," he said. "People need targeted interventions that encourage physical activity alongside medication for obesity."FITNESS EXPERT REVEALS SIMPLE RULE TO GET IN SHAPE WITHOUT DREADING THE GYM: 'JUST MOVE'The study was retrospective and observational, meaning it could only display an association, not a direct cause. The participants were also mostly middle-aged women, which could limit the scope of who is most impacted, the researchers noted.Other factors that were not measured include exercise habits before starting treatment, motivation levels and guidance from a physician.Dr. Peter Balazs MD, a hormone and weight-loss specialist practicing in New York and New Jersey, echoed in an interview with Fox News Digital that weight loss does not automatically lead to increased mobility or greater motivation to exercise."In fact, being in… [TheTopNews] Read More.
3 days ago
The Searchable USWebDaily.com and TheTopNews NewsBank Helps You Be Better Informed, Faster! Spread The Word.
